Femara (Letrozole) for PCOS

Overview
Femara is a prescription drug approved by the Food and Drug Administration (FDA) to treat breast cancer in postmenopausal women. Femara is also referred to by its drug name, Letrozole. In women with polycystic ovary syndrome (PCOS), Femara may be prescribed as treatment for infertility. Since Femara is not FDA-approved to treat infertility, this usage may be considered “off-label.”

Femara is an aromatase inhibitor that is used as a fertility medication. Femara is believed to work by stimulating ovulation.

How do I take it?
Prescribing information states that Femara is taken once a day.

Femara comes in tablet form.

Side effects
The FDA-approved label for Femara lists common side effects including headache, dizziness, flushing, joint pain, swelling (edema), bone pain, a rise in cholesterol, and increased sweating.

Rare but serious side effects listed for Femara include a decrease in bone mineral density.

For more details about this treatment, visit:
Femara – Novartis
https://www.femara.com/index.jsp